PT89927A - Processo para a preparacao de agentes citotoxicos especificados para celulas - Google Patents

Processo para a preparacao de agentes citotoxicos especificados para celulas

Info

Publication number
PT89927A
PT89927A PT89927A PT8992789A PT89927A PT 89927 A PT89927 A PT 89927A PT 89927 A PT89927 A PT 89927A PT 8992789 A PT8992789 A PT 8992789A PT 89927 A PT89927 A PT 89927A
Authority
PT
Portugal
Prior art keywords
cells
preparing
agents specified
citotoxic
citotoxic agents
Prior art date
Application number
PT89927A
Other languages
English (en)
Inventor
Clarence L Villemez
Dean A Myers
Original Assignee
Univ Wyoming
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Wyoming filed Critical Univ Wyoming
Publication of PT89927A publication Critical patent/PT89927A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/34—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Corynebacterium (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Obesity (AREA)
  • Transplantation (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PT89927A 1988-03-08 1989-03-07 Processo para a preparacao de agentes citotoxicos especificados para celulas PT89927A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16521388A 1988-03-08 1988-03-08

Publications (1)

Publication Number Publication Date
PT89927A true PT89927A (pt) 1989-11-10

Family

ID=22597941

Family Applications (1)

Application Number Title Priority Date Filing Date
PT89927A PT89927A (pt) 1988-03-08 1989-03-07 Processo para a preparacao de agentes citotoxicos especificados para celulas

Country Status (7)

Country Link
EP (1) EP0332174A3 (pt)
JP (1) JPH0215099A (pt)
AU (1) AU632995B2 (pt)
CA (1) CA1340612C (pt)
DK (1) DK113689A (pt)
IL (1) IL89504A0 (pt)
PT (1) PT89927A (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5314995A (en) * 1990-01-22 1994-05-24 Oncogen Therapeutic interleukin-2-antibody based fusion proteins
EP0517829B2 (en) * 1990-03-02 2007-12-26 Boston Medical Center Corporation Improved chimeric toxins
NO175188C (no) * 1990-06-27 1994-09-14 Sjur Olsnes Fremgangsmåte for fremstilling av et peptidkonjugat med evne til å trenge inn i cellecytosol
US5858363A (en) * 1990-07-20 1999-01-12 Pharmacia & Upjohn Ab Target specific antibody-superantigen conjugates and their preparation
JP3334130B2 (ja) * 1990-07-20 2002-10-15 フアルマシア・アクチエボラーグ 抗体接合体
JPH06510750A (ja) * 1991-05-03 1994-12-01 セラジェン　インク 炎症性関節炎治療を目的としてインタ−ロイキン受容体を標的にした分子
DE69324487T2 (de) * 1992-05-06 1999-08-12 Harvard College Rezeptorbindende region des diphtherietoxius
US7288254B2 (en) 1995-10-30 2007-10-30 The United States Of America As Represented By The Secretary, Department Of Health And Human Services, Nih Use of immunotoxins to induce immune tolerance to pancreatic islet transplantation
US7517527B2 (en) 1995-10-30 2009-04-14 The United States Of America As Represented By The Department Of Health And Human Services Immunotoxin with in vivo T cell suppressant activity and methods of use
US7696338B2 (en) 1995-10-30 2010-04-13 The United States Of America As Represented By The Department Of Health And Human Services Immunotoxin fusion proteins and means for expression thereof
US7125553B1 (en) 1996-04-15 2006-10-24 The United States of America as represented by the Department of Health and Human Services c/o Centers for Disease Control and Prevention Methods of inducing immune tolerance using immunotoxins
DE69840913D1 (de) 1997-03-05 2009-07-30 Us Health Divalent anti-t-zellen immuntoxinen und deren verwendung
EP0968282A2 (en) * 1997-03-05 2000-01-05 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Vectors and methods for expression of mutant proteins
JP7041414B2 (ja) 2018-10-31 2022-03-24 Smc株式会社 電磁弁

Also Published As

Publication number Publication date
EP0332174A2 (en) 1989-09-13
AU3110389A (en) 1989-10-12
AU632995B2 (en) 1993-01-21
EP0332174A3 (en) 1990-12-19
DK113689A (da) 1989-09-09
CA1340612C (en) 1999-06-29
DK113689D0 (da) 1989-03-08
JPH0215099A (ja) 1990-01-18
IL89504A0 (en) 1989-09-10

Similar Documents

Publication Publication Date Title
PT82890B (pt) Processo para a preparacao de novos derivados de n-aralquil-piperidinametanol
PT88369A (pt) Processo para a preparacao de comprimidos com bioadesao superior as menbranas mosas
PT99409A (pt) Processo para a preparacao de benzimidazois polissubstituidos
PT97906A (pt) Processo para a preparacao de novos derivados de tiofeno
BR8804535A (pt) Processo para a obtencao de c8-ate c24-alquiloligoglicosidios e-alquilglicosidios
PT90293A (pt) Processo para a preparacao de macrolidos
BR8902112A (pt) Processo para preparacao de um detergente em po
PT96411A (pt) Processo para a preparacao de derivados de azaoxindole
BR8907013A (pt) Processo para preparacao de uma dimetiltetralina
PT89927A (pt) Processo para a preparacao de agentes citotoxicos especificados para celulas
PT84124B (pt) Processo para a preparacao duma composicao estavel de nicorandilo
PT90854A (pt) Processo para a preparacao de 1-aril-2-naftoilaminas
BR8906327A (pt) Processo para a preparacao de organoclorossilanos
PT89836A (pt) Processo para a preparacao de amlodipina "r" e "s"
PT92638A (pt) Processo para a preparacao de poliazamacrociclos mono-n-alquilados
PT82445B (pt) Processo para a preparacao de novos derivados glicopeptidicos
PT84818B (pt) Processo para a preparacao de derivados de di-hidro-oxazol, di-hidro-tiazol e di-hidro-imidazol
PT89026A (pt) Processo para a preparacao de factor de activacao dos neutrofilos
BR9007734A (pt) Processo para a obtencao de alquil-polietoxietersulfatos
PT84587B (pt) Processo para preparacao de uma enzima fibrinolitica
PT96322A (pt) Processo para a preparacao de derivados de glicerol
PT91205A (pt) Processo para a preparacao de 2-aminopurina
BR8903367A (pt) Processo para a preparacao de organoclorossilanos
PT87869A (pt) Processo para a preparacao de um activador de plasminogenio hibrido
BR8905956A (pt) Processo para a preparacao de acidos

Legal Events

Date Code Title Description
FC3A Refusal

Effective date: 19940307